Literature DB >> 9927495

Neuroprotective effects of gelsolin during murine stroke.

M Endres1, K Fink, J Zhu, N E Stagliano, V Bondada, J W Geddes, T Azuma, M P Mattson, D J Kwiatkowski, M A Moskowitz.   

Abstract

Increased Ca2+ influx through activated N-methyl-D-aspartate (NMDA) receptors and voltage-dependent Ca2+ channels (VDCC) is a major determinant of cell injury following brain ischemia. The activity of these channels is modulated by dynamic changes in the actin cytoskeleton, which may occur, in part, through the actions of the actin filament-severing protein gelsolin. We show that gelsolin-null neurons have enhanced cell death and rapid, sustained elevation of Ca2+ levels following glucose/oxygen deprivation, as well as augmented cytosolic Ca2+ levels in nerve terminals following depolarization in vitro. Moreover, major increases in infarct size are seen in gelsolin-null mice after reversible middle cerebral artery occlusion, compared with controls. In addition, treatment with cytochalasin D, a fungal toxin that depolymerizes actin filaments, reduced the infarct size of both gelsolin-null and control mice to the same final volume. Hence, enhancement or mimicry of gelsolin activity may be neuroprotective during stroke.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9927495      PMCID: PMC407902          DOI: 10.1172/JCI4953

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  Modulation of gelsolin function by phosphatidylinositol 4,5-bisphosphate.

Authors:  P A Janmey; T P Stossel
Journal:  Nature       Date:  1987 Jan 22-28       Impact factor: 49.962

Review 2.  Glutamate neurotoxicity and diseases of the nervous system.

Authors:  D W Choi
Journal:  Neuron       Date:  1988-10       Impact factor: 17.173

3.  A semiautomated method for measuring brain infarct volume.

Authors:  R A Swanson; M T Morton; G Tsao-Wu; R A Savalos; C Davidson; F R Sharp
Journal:  J Cereb Blood Flow Metab       Date:  1990-03       Impact factor: 6.200

4.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

5.  Fibroblast growth factor and glutamate: opposing roles in the generation and degeneration of hippocampal neuroarchitecture.

Authors:  M P Mattson; M Murrain; P B Guthrie; S B Kater
Journal:  J Neurosci       Date:  1989-11       Impact factor: 6.167

6.  NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones.

Authors:  A B MacDermott; M L Mayer; G L Westbrook; S J Smith; J L Barker
Journal:  Nature       Date:  1986 May 29-Jun 4       Impact factor: 49.962

7.  The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat.

Authors:  C K Park; D G Nehls; D I Graham; G M Teasdale; J McCulloch
Journal:  Ann Neurol       Date:  1988-10       Impact factor: 10.422

8.  Outgrowth-regulating actions of glutamate in isolated hippocampal pyramidal neurons.

Authors:  M P Mattson; P Dou; S B Kater
Journal:  J Neurosci       Date:  1988-06       Impact factor: 6.167

9.  Genomic organization and biosynthesis of secreted and cytoplasmic forms of gelsolin.

Authors:  D J Kwiatkowski; R Mehl; H L Yin
Journal:  J Cell Biol       Date:  1988-02       Impact factor: 10.539

10.  Identification of critical functional and regulatory domains in gelsolin.

Authors:  D J Kwiatkowski; P A Janmey; H L Yin
Journal:  J Cell Biol       Date:  1989-05       Impact factor: 10.539

View more
  37 in total

1.  Gelsolin and ADF/cofilin enhance the actin dynamics of motile cells.

Authors:  F S Southwick
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

Review 2.  Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders.

Authors:  Mark P Mattson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

3.  Genetics of alcohol use disorders: Actin gets into the act.

Authors:  Golo Kronenberg; Matthias Endres; Karen Gertz
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-29       Impact factor: 11.205

4.  Calcium induces expression of cytoplasmic gelsolin in SH-SY5Y and HEK-293 cells.

Authors:  Lina Ji; Abha Chauhan; Ved Chauhan
Journal:  Neurochem Res       Date:  2010-03-26       Impact factor: 3.996

5.  Mild cerebral ischemia induces loss of cyclin-dependent kinase inhibitors and activation of cell cycle machinery before delayed neuronal cell death.

Authors:  J Katchanov; C Harms; K Gertz; L Hauck; C Waeber; L Hirt; J Priller; R von Harsdorf; W Bruck; H Hortnagl; U Dirnagl; P G Bhide; M Endres
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

6.  Plasma-type gelsolin is decreased in human blood and cerebrospinal fluid after subarachnoid hemorrhage.

Authors:  Sherry H-Y Chou; Po-Shun Lee; Rachael G Konigsberg; Dana Gallacci; Terry Chiou; Ken Arai; Suzanne Simmons; David Bauer; Steven K Feske; Eng H Lo; MingMing Ning
Journal:  Stroke       Date:  2011-09-22       Impact factor: 7.914

7.  ICAM-1null C57BL/6 Mice Are Not Protected from Experimental Ischemic Stroke.

Authors:  Gaby U Enzmann; Sofia Pavlidou; Markus Vaas; Jan Klohs; Britta Engelhardt
Journal:  Transl Stroke Res       Date:  2018-02-04       Impact factor: 6.829

8.  Delayed activin A administration attenuates tissue death after transient focal cerebral ischemia and is associated with decreased stress-responsive kinase activation.

Authors:  Shibani S Mukerji; Riley N Rainey; Jamie L Rhodes; Alison K Hall
Journal:  J Neurochem       Date:  2009-09-24       Impact factor: 5.372

9.  Gelsolin restores A beta-induced alterations in choroid plexus epithelium.

Authors:  Teo Vargas; Desiree Antequera; Cristina Ugalde; Carlos Spuch; Eva Carro
Journal:  J Biomed Biotechnol       Date:  2010-03-25

10.  Induction of neuro-protective/regenerative genes in stem cells infiltrating post-ischemic brain tissue.

Authors:  Gokhan Yilmaz; J Steven Alexander; Cigdem Erkuran Yilmaz; D Neil Granger
Journal:  Exp Transl Stroke Med       Date:  2010-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.